Detrimental role of hyperuricemia on the cardio-reno-vascular system

Area of Science:

• Cardiology
• Nephrology
• Rheumatology

Background:

• Growing evidence links gout to adverse cardiovascular (CV) outcomes.
• Hyperuricemia, a hallmark of gout, is suspected but not definitively proven as an independent CV risk factor.
• Confounding by traditional CV risk factors complicates the gout-cardiovascular relationship.

Purpose of the Study:

• To critically evaluate the evidence supporting a causal relationship between gout/hyperuricemia and major CV and renal events.
• To assess the strength of proof from biological, epidemiological, and clinical trial data.
• To clarify the independent role of hyperuricemia in cardiovascular and renal disease.

Main Methods:

• Comprehensive literature review of studies on hyperuricemia and cardiovascular/renal function.
• Search conducted using PubMed and Embase databases.
• Analysis of biological, epidemiological, and clinical trial evidence.

Main Results:

• Existing evidence suggests a link between gout and adverse CV outcomes.
• The independent causative role of hyperuricemia remains uncertain due to confounding factors.
• Further research is needed to establish causality.

Conclusions:

• While gout is associated with cardiovascular events, hyperuricemia's independent contribution requires more robust evidence.
• Traditional CV risk factors often coexist in gout patients, complicating direct causal attribution.
• The review highlights the need for studies that can definitively isolate hyperuricemia's impact on CV and renal health.